Sovaldi and Harvoni land on 13 hospitals and start to be supplied

Prescriptions of ‘Sovaldi(sofosbuvir),’ a large hepatitis C treatment, and ‘Harvoni(sofosbuvir and ledipasvir),’ a complex, have started in the domestic market.

Gilead Sciences Korea announced supply of the two oral treatments of chronic hepatitis C without the health insurance benefits from the last 4^th.

The two drugs passed drug committees(DCs) of the total 13 major hospitals and landed on ...